Spectrum Pharma (SPPI) Posts Weaker Q1 Results
Spectrum Pharmaceuticals, Inc. (Nasdaq: SPPI) reports Q1 loss of $0.80, versus the analyst estimate of ($0.15). Revenue for the quarter was $11.1 million, which compares to the estimate of $9.88 million.
You May Also Be Interested In
- Tesla (TSLA) Offers to Acquire SolarCity (SCTY) for $26.50-$28.50/Share
- Sonic Corp (SONC) Tops Q3 EPS by 1c
- Steelcase (SCS) Tops Q1 EPS by 2c; Issues Light Q2 Outlook
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!